Varipulse Catheter for Paroxysmal Atrial Fibrillation Under Sedation
Part of Heart & circulation clinical trials.
This study tests a new type of catheter (Varipulse) to treat paroxysmal atrial fibrillation (AFib that comes and goes) using a procedure done under sedation. It aims to see if the catheter is safe and effective for people whose symptoms aren't controlled by medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have atrial fibrillation that comes and goes (paroxysmal) and causes symptoms like palpitations, shortness of breath, or fatigue, even after trying medications.
- You have not had a previous catheter ablation or surgery on the left atrium (the upper left chamber of your heart).
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You are willing to follow all study procedures and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new catheter system, called Varipulse, to see if it's safe and effective for treating atrial fibrillation (AF), a heart rhythm problem. People with short-lasting AF who haven't been helped by medication may be able to join.
This study tests a new catheter to treat persistent atrial fibrillation (a type of irregular heartbeat lasting more than 7 days but less than a year). It aims to isolate the pulmonary veins and superior vena cava to restore normal rhythm. Some participants may also receive a left atrial appendage occlusion device if needed.
This study tests a new catheter and generator system to treat persistent atrial fibrillation (an irregular heartbeat that lasts more than a week). It may help people whose symptoms haven't been controlled by medication and who need a procedure called ablation to fix the heart's electrical signals.
This study tests a new type of catheter ablation (a procedure that uses energy to treat irregular heartbeats) for atrial fibrillation—a common heart rhythm problem. You may qualify if you have recurring irregular heartbeats that haven't responded well to heart medications and are planning to have this procedure.
This study tests a new way to treat atrial fibrillation (Afib) using a special catheter system called PulseSelect that delivers short bursts of energy to create scar tissue in the heart. It is for people whose Afib comes and goes or stays for a while but not more than a year, and who have not had a prior ablation procedure or have a pacemaker or defibrillator.
This study compares two different catheters that use pulsed field ablation to treat a type of irregular heartbeat called persistent atrial fibrillation. The goal is to see which one works better and is safer.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.